Application of multimodal MR imaging on studying Alzheimer's disease: A survey

Current Alzheimer Research

Volumn 10, Issue 8, 2013, Pages 877-892

  Wang, Defeng ^a   Hui, Steve C N ^a   Shi, Lin ^a,b   Huang, Wen hua ^c   Wang, Tianfu ^d   Mok, Vincent C T ^a   Chu, Winnie C W ^a   Ahuja, Anil T ^a  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b SHENZHEN INSTITUTES OF ADVANCED TECHNOLOGY   (China)

^c SOUTHERN MEDICAL UNIVERSITY   (China)

^d Shenzhen University School of Medicine   (China)

Author keywords

Alzheimer's disease; Amyloid; DTI; fMRI; MRS; Multimodal MRI; Tau pathology

Indexed keywords

ALZHEIMER DISEASE; BRAIN ATROPHY; BRAIN FUNCTION; BRAIN SIZE; DIFFUSION TENSOR IMAGING; ELASTOGRAPHY; ENTORHINAL CORTEX; FRONTAL LOBE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; HUMAN; IMAGE ANALYSIS; MAGNETIC RESONANCE ELASTOGRAPHY; MEDIAL TEMPORAL LOBE; NUCLEAR MAGNETIC RESONANCE; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PARIETAL LOBE; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; REVIEW; SPIN LABELING; SUSCEPTIBILITY WEIGHTED IMAGING; TEMPORAL LOBE; WHITE MATTER;

ALZHEIMER DISEASE; BRAIN; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; NERVE FIBERS, MYELINATED;

EID: 84888062624     PISSN: 15672050     EISSN: 18755828     Source Type: Journal    
DOI: 10.2174/15672050113109990150     Document Type: Review

References (109)

1. Assoc A. Alzheimer's Association Report 2011 Alzheimer's disease facts and figures. Alzheimers Dement 7(2): 208-44 (2011).
2. International AsD. National Alzheimer and Dementia Plans Planned Policies and Activities. 2012.
3. Wierenga CE, Bondi MW. Use of functional magnetic resonance imaging in the early identification of Alzheimer's disease. Neuropsychol Rev 17(2): 127-43 (2007).
4. Blennow K, de Leon MJ, Zetterberg H. Alzheimer's disease. Lancet 368(9533): 387-403 (2006).
5. Tondelli M, Wilcock GK, Nichelli P, De Jager CA, Jenkinson M, Zamboni G. Structural MRI changes detectable up to ten years before clinical Alzheimer's disease. Neurobiol Aging 33(4) (2012).
6. Agosta F, Pievani M, Geroldi C, Copetti M, Frisoni GB, Filippi M. Resting state fMRI in Alzheimer's disease: beyond the default mode network. Neurobiol Aging 33(8): 1564-78 (2012).
7. Clerx L, Visser PJ, Verhey F, Aalten P. New MRI Markers for Alzheimer's Disease: A Meta-Analysis of Diffusion Tensor Imaging and a Comparison with Medial Temporal Lobe Measurements. J Alzheimers Dis 29(2): 405-29 (2012).
8. Jack CR, Albert MS, Knopman DS, McKhann GM, Sperling RA, Carrillo MC, et al. Introduction to the recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7(3): 257-62 (2011).
9. Albert MS, DeKosky ST, Dickson D, Dubois B, Feldman HH, Fox NC, et al. The diagnosis of mild cognitive impairment due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement 7(3): 270-9 (2011).
10. Rusinek H, De Santi S, Frid D, Tsui WH, Tarshish CY, Convit A, et al. Regional brain atrophy rate predicts future cognitive decline: 6-year longitudinal MR imaging study of normal aging. Radiology 229(3): 691-6 (2003).
11. Jack CR, Petersen RC, Xu Y, O'Brien PC, Smith GE, Ivnik RJ, et al. Rates of hippocampal atrophy correlate with change in clinical status in aging and AD. Neurology 55(4): 484-9 (2000).
12. Thompson PM, Hayashi KM, de Zubicaray G, Janke AL, Rose SE, Semple J, et al. Dynamics of gray matter loss in Alzheimer's disease. J Neurosci 23(3): 994-1005 (2003).
13. Naggara O, Oppenheim C, Rieu D, Raoux N, Rodrigo S, Dalla Barba G, et al. Diffusion tensor imaging in early Alzheimer's disease. Psychiat Res-Neuroim 146(3): 243-9 (2006).
14. Braak H, Braak E. Neuropathological stageing of Alzheimerrelated changes. Acta Neuropathol 82(4): 239-59 (1991).
15. Rusinek H, de Leon MJ, George AE, Stylopoulos LA, Chandra R, Smith G, et al. Alzheimer disease: measuring loss of cerebral gray matter with MR imaging. Radiology 178(1): 109-14 (1991).
16. Josephs KA, Whitwell JL, Ahmed Z, Shiung MM, Weigand SD, Knopman DS, et al. Beta-amyloid burden is not associated with rates of brain atrophy. Ann Neurol 63(2): 204-12 (2008).
17. Whitwell JL, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, Petersen RC, et al. 3D maps from multiple MRI illustrate changing atrophy patterns as subjects progress from mild cognitive impairment to Alzheimer's disease. Brain 130: 1777-86 (2007).
18. Whitwell JL, Shiung MM, Przybelski SA, Weigand SD, Knopman DS, Boeve BF, et al. MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment. Neurology 70(7): 512-20 (2008).
19. Hua X, Leow AD, Lee S, Klunder AD, Toga AW, Lepore N, et al. 3D characterization of brain atrophy in Alzheimer's disease and mild cognitive impairment using tensor-based morphometry. Neuroimage 41(1): 19-34 (2008).
20. Leow AD, Yanovsky I, Parikshak N, Hua X, Lee S, Toga AW, et al. Alzheimer's Disease Neuroimaging Initiative: A one-year follow up study using tensor-based morphometry correlating degenerative rates, biomarkers and cognition. Neuroimage 45(3): 645-55 (2009).
21. Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, et al. Automated 3D mapping of hippocampal atrophy and its clinical correlates in 400 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Human brain mapping 30(9): 2766-88 (2009).
22. Morra JH, Tu Z, Apostolova LG, Green AE, Avedissian C, Madsen SK, et al. Automated mapping of hippocampal atrophy in 1-year repeat MRI data from 490 subjects with Alzheimer's disease, mild cognitive impairment, and elderly controls. Neuroimage 45(1): S3-15 (2009).
23. Scher AI, Xu Y, Korf ES, White LR, Scheltens P, Toga AW, et al. Hippocampal shape analysis in Alzheimer's disease: a populationbased study. Neuroimage 36(1): 8-18 (2007).
24. Shi F, Liu B, Zhou Y, Yu C, Jiang T. Hippocampal volume and asymmetry in mild cognitive impairment and Alzheimer's disease: Meta-analyses of MRI studies. Hippocampus 19(11): 1055-64 (2009).
25. Holland D, Brewer JB, Hagler DJ, Fennema-Notestine C, Dale AM. Subregional neuroanatomical change as a biomarker for Alzheimer's disease. Proc Natl Acad Sci U S A 106(49): 20954-9 (2009).
26. Ridha BH, Anderson VM, Barnes J, Boyes RG, Price SL, Rossor MN, et al. Volumetric MRI and cognitive measures in Alzheimer disease: comparison of markers of progression. Journal of neurology 255(4): 567-74 (2008).
27. Sluimer JD, Vrenken H, Blankenstein MA, Fox NC, Scheltens P, Barkhof F, et al. Whole-brain atrophy rate in Alzheimer disease: identifying fast progressors. Neurology 70(19 Pt 2): 1836-41 (2008).
28. Frisoni GB, Ganzola R, Canu E, Rüb U, Pizzini FB, Alessandrini F, et al. Mapping local hippocampal changes in Alzheimer's disease and normal ageing with MRI at 3 Tesla. Brain 131(Pt 12): 3266-76 (2008).
29. Frisoni GB, Prestia A, Rasser PE, Bonetti M, Thompson PM. In vivo mapping of incremental cortical atrophy from incipient to overt Alzheimer's disease. J Neuroly 256(6): 916-24 (2009).
30. Fjell AM, Walhovd KB, Fennema-Notestine C, McEvoy LK, Hagler DJ, Holland D, et al. One-year brain atrophy evident in healthy aging. J Neurosci 29(48): 15223-31 (2009).
31. Leung KK, Barnes J, Ridgway GR, Bartlett JW, Clarkson MJ, Macdonald K, et al. Automated cross-sectional and longitudinal hippocampal volume measurement in mild cognitive impairment and Alzheimer's disease. Neuroimage 51(4): 1345-59 (2010).
32. Wattjes MP. Structural MRI. International psychogeriatrics/IPA 2011; 23 Suppl 2: S13-24.
33. Frisoni GB, Fox NC, Jack CR, Jr., Scheltens P, Thompson PM. The clinical use of structural MRI in Alzheimer disease. Nature reviews Neurology 6(2): 67-77 (2010).
34. Prvulovic D, Bokde AL, Faltraco F, Hampel H. Functional magnetic resonance imaging as a dynamic candidate biomarker for Alzheimer's disease. Progress Neurobiol 95(4): 557-69 (2011).
35. Logothetis NK, Wandell BA. Interpreting the BOLD signal. Annu Rev Physiol 66: 735-69 (2004).
36. Bookheimer SY, Strojwas MH, Cohen MS, Saunders AM, Pericak-Vance MA, Mazziotta JC, et al. Patterns of brain activation in people at risk for Alzheimer's disease. The New England journal of medicine 343(7): 450-6 (2000).
37. Filbey FM, Slack KJ, Sunderland TP, Cohen RM. Functional magnetic resonance imaging and magnetoencephalography differences associated with APOEepsilon4 in young healthy adults. Neuroreport 2006; 17(15): 1585-90.
38. Gould RL, Arroyo B, Brown RG, Owen AM, Bullmore ET, Howard RJ. Brain mechanisms of successful compensation during learning in Alzheimer disease. Neurology 67(6): 1011-7 (2006).
39. Dickerson BC, Sperling RA. Functional abnormalities of the medial temporal lobe memory system in mild cognitive impairment and Alzheimer's disease: insights from functional MRI studies. Neuropsychologia 46(6): 1624-35 (2008).
40. Vannini P, Almkvist O, Dierks T, Lehmann C, Wahlund LO. Reduced neuronal efficacy in progressive mild cognitive impairment: a prospective fMRI study on visuospatial processing. Psychiatry Res 156(1): 43-57 (2007).
41. Prvulovic D, Hubl D, Sack AT, et al. Functional imaging of visuospatial processing in Alzheimer's disease. Neuroimage 17(3): 1403-14 (2002).
42. Mevel K, Chetelat G, Eustache F, Desgranges B. The default mode network in healthy aging and Alzheimer's disease. International journal of Alzheimer's disease 2011: 535816 (2011).
43. Rosazza C, Minati L. Resting-state brain networks: literature review and clinical applications. Neurological sciences: official journal of the Italian Neurological Society and of the Italian Society of Clin Neurophysiol 32(5): 773-85 (2011).
44. Raichle ME, MacLeod AM, Snyder AZ, Powers WJ, Gusnard DA, Shulman GL. A default mode of brain function. Proc Natl Acad Sci U S A 98(2): 676-82 (2001).
45. Raichle ME, Snyder AZ. A default mode of brain function: a brief history of an evolving idea. Neuroimage 37(4): 1083-90 (2007).
46. Buckner RL, Andrews-Hanna JR, Schacter DL. The brain's default network: anatomy, function, and relevance to disease. Ann N Y Acad Sci 1124: 1-38 (2008).
47. Greicius MD, Srivastava G, Reiss AL, Menon V. Default-mode network activity distinguishes Alzheimer's disease from healthy aging: evidence from functional MRI. Proc Natl Acad Sci U S A 101(13): 4637-42 (2004).
48. Chua TC, Wen W, Slavin MJ, Sachdev PS. Diffusion tensor imaging in mild cognitive impairment and Alzheimer's disease: a review. Curr Opin Neurobiol 21(1): 83-92 (2008).
49. Le Bihan D, Mangin JF, Poupon C, Clark CA, Pappata S, Molko N, et al. Diffusion tensor imaging: concepts and applications. J Cardiovasc Magn Imaging 13(4): 534-46 (2001).
50. Medina D, DeToledo-Morrell L, Urresta F, et al. White matter changes in mild cognitive impairment and AD: A diffusion tensor imaging study. Neurobiol Aging 2006; 27(5): 663-72.
51. Brun A, Englund E. A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 19(3): 253-62 (1986).
52. Englund E. Neuropathology of white matter changes in Alzheimer's disease and vascular dementia. Dement Geriatr Cogn Disord 9(1): 6-12 (1998).
53. Stebbins GT, Murphy CM. Diffusion tensor imaging in Alzheimer's disease and mild cognitive impairment. Behav Neurol 21(1): 39-49 (2009).
54. Damoiseaux JS, Smith SM, Witter MP, et al. White matter tract integrity in aging and Alzheimer's disease. Human brain mapping 2009; 30(4): 1051-9.
55. Head D, Buckner RL, Shimony JS, Williams LE, Akbudak E, Conturo TE, et al. Differential vulnerability of anterior white matter in nondemented aging with minimal acceleration in dementia of the Alzheimer type: evidence from diffusion tensor imaging. Cereb Cortex 14(4): 410-23 (2004).
56. Liao J, Zhu Y, Zhang M, Yuan H, Su MY, Yu X, et al. Microstructural White Matter Abnormalities Independent of White Matter Lesion Burden in Amnestic Mild Cognitive Impairment and Early Alzheimer Disease Among Han Chinese Elderly. Alzheimer disease and associated disorders (2010).
57. Zhang Y, Schuff N, Jahng GH, Bayne W, Mori S, Schad L, et al. Diffusion tensor imaging of cingulum fibers in mild cognitive impairment and Alzheimer disease. Neurology 68(1): 13-9 (2007).
58. Mori S, Crain BJ, Chacko VP, van Zijl PC. Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol 45(2): 265-9 (1999).
59. Conturo TE, Lori NF, Cull TS, Akbudak E, Snyder AZ, Shimony JS, et al. Tracking neuronal fiber pathways in the living human brain. Proc Natl Acad Sci U S A 96(18): 10422-7 (1999).
60. Basser PJ, Pajevic S, Pierpaoli C, Duda J, Aldroubi A. In vivo fiber tractography using DT-MRI data. Magnetic resonance in medicine: official journal of the Society of Magnetic Resonance in Medicine/Society of Magnetic Resonance in Medicine 44(4): 625-32 (2000).
61. Assaf Y, Pasternak O. Diffusion tensor imaging (DTI)-based white matter mapping in brain research: a review. J Mol Neurosci 34(1): 51-61 (2008).
62. Yasmin H, Nakata Y, Aoki S, Abe O, Sato N, Nemoto K, et al. Diffusion abnormalities of the uncinate fasciculus in Alzheimer's disease: diffusion tensor tract-specific analysis using a new method to measure the core of the tract. Neuroradiology 50(4): 293-9 (2008).
63. Taoka T, Morikawa M, Akashi T, Miyasaka T, Nakagawa H, Kiuchi K, et al. Fractional anisotropy--threshold dependence in tractbased diffusion tensor analysis: evaluation of the uncinate fasciculus in Alzheimer disease. AJNR Am J Neuroradiol 30(9): 1700-3 (2009).
64. Pievani M, Agosta F, Pagani E, Canu E, Sala S, Absinta M, et al. Assessment of white matter tract damage in mild cognitive impairment and Alzheimer's disease. Human brain mapping 31(12): 1862-75 (2010).
65. Xie S, Xiao JX, Wang YH, Wu HK, Gong GL, Jiang XX. Evaluation of bilateral cingulum with tractography in patients with Alzheimer's disease. Neuroreport 16(12): 1275-8 (2005).
66. Kiuchi K, Morikawa M, Taoka T, Nagashima T, Yamauchi T, Makinodan M, et al. Abnormalities of the uncinate fasciculus and posterior cingulate fasciculus in mild cognitive impairment and early Alzheimer's disease: a diffusion tensor tractography study. Brain Res 1287: 184-91 (2009).
67. Nakata Y, Sato N, Abe O, Shikakura S, Arima K, Furuta N, et al. Diffusion abnormality in posterior cingulate fiber tracts in Alzheimer's disease: tract-specific analysis. Radiat Med 26(8): 466-73 (2008).
68. Brooks WM, Stidley CA, Petropoulos H, Jung RE, Weers DC, Friedman SD, et al. Metabolic and cognitive response to human traumatic brain injury: a quantitative proton magnetic resonance study. J Neurotrauma 17(8): 629-40 (2000).
69. Loos C, Achten E, Santens P. Proton magnetic resonance spectroscopy in Alzheimer's disease, a review. Acta neurologica Belgica 110(4): 291-8 (2010).
70. Jessen F, Gur O, Block W, Ende G, Frölich L, Hammen T, et al. A multicenter (1)H-MRS study of the medial temporal lobe in AD and MCI. Neurology 72(20): 1735-40 (2009).
71. Miller BL, Moats RA, Shonk T, Ernst T, Woolley S, Ross BD. Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology 187(2): 433-7 (1993).
72. Moats RA, Ernst T, Shonk TK, Ross BD. Abnormal cerebral metabolite concentrations in patients with probable Alzheimer disease. Magn Reson Med 32(1): 110-5 (1994).
73. Schuff N, Amend DL, Meyerhoff DJ, Tanabe JL, Norman D, Fein G, et al. Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain. Radiology 207(1): 91-102 (1998).
74. Kantarci K, Knopman DS, Dickson DW, Parisi JE, Whitwell JL, Weigand SD, et al. Alzheimer disease: postmortem neuropathologic correlates of antemortem 1H MR spectroscopy metabolite measurements. Radiology 248(1): 210-20 (2008).
75. Lazeyras F, Charles HC, Tupler LA, Erickson R, Boyko OB, Krishnan KR. Metabolic brain mapping in Alzheimer's disease using proton magnetic resonance spectroscopy. Psychiatry Res 82(2): 95-106 (1998).
76. Scott CJM, Szilagyi GM, Chavez S, Ganda A, Black SE. Applications of chemical shift imaging for AD. Curr Med Imaging Rev 7(1): 88-95 (2011).
77. Scott CJ. M. CS, Graham S. J., Black S. E. 2-D Chemical-Shift Imaging of white matter hyperintensities in Alzheimer's Disease-a qualitative analysis. Can Geriatr J 12(3): 142 (2009).
78. Alsop DC, Dai W, Grossman M, Detre JA. Arterial spin labeling blood flow MRI: its role in the early characterization of Alzheimer's disease. J Alzheimers Dis 20(3): 871-80 (2010).
79. van Osch MJP, Lu H. Arterial spin labeling perfusion MRI in alzheimer's disease. Curr Med Imag Rev 7(1): 62-72 (2011).
80. Muthupillai R, Lomas DJ, Rossman PJ, Greenleaf JF, Manduca A, Ehman RL. Magnetic resonance elastography by direct visualization of propagating acoustic strain waves. Science 269(5232): 1854-7 (1995).
81. Murphy MC, Huston J, 3rd, Jack CR, Jr., Glaser KJ, Manduca A, Felmlee JP, et al. Decreased brain stiffness in Alzheimer's disease determined by magnetic resonance elastography. J Magn Reson 34(3): 494-8 (2011).
82. Larrat B, Chan QC, Yang XF, et al. editors. Anisotropic viscoelastic properties of the corpus callosum-Application of highresolution 3D MR-elastography to an Alzheimer mouse model. 2007.
83. Murphy MC, Curran GL, Glaser KJ, Rossman PJ, Huston J 3rd, Poduslo JF, et al. Magnetic resonance elastography of the brain in a mouse model of Alzheimer's disease: initial results. Magn Reson Imaging 30(4): 535-9 (2012).
84. Hegde ML, Bharathi P, Suram A, Venugopal C, Jagannathan R, Poddar P, et al. Challenges associated with metal chelation therapy in Alzheimer's disease. J Alzheimers Dis 17(3): 457-68 (2009).
85. Zhang J, Wang J, Li K, et al. Correlation between iron deposition and alzheimer's disease: In vivo preliminary quantitative study with susceptibility-weighted imaging. Neural Regeneration Research 5(10): 725-8 (2010).
86. Ku HL, Chi NF. Cerebral lobar microhemorrhages detection by high magnetic field susceptibility weighted image: a potential diagnostic neuroimage technique of Alzheimer's disease. Med Hypotheses 76(6): 840-2 (2011).
87. Apostolova LG, Mosconi L, Thompson PM, Green AE, Hwang KS, Ramirez A, et al. Subregional hippocampal atrophy predicts Alzheimer's dementia in the cognitively normal. Neurobiol Aging 31(7): 1077-88 (2010).
88. Lacoboni MFJ, Kaplan J. This Is Your Brain on Politics. The New York Times 2007 November.
89. Wahlund LO, Julin P, Johansson SE, Scheltens P. Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study. J Neurol Neurosurg Psychiatry 69(5): 630-5 (2000).
90. Golebiowski M, Barcikowska M, Pfeffer A. Magnetic resonance imaging-based hippocampal volumetry in patients with dementia of the Alzheimer type. Dement Geriatr Cogn Disord 10(4): 284-8 (1999).
91. Juottonen K, Laakso MP, Partanen K, Soininen H. Comparative MR analysis of the entorhinal cortex and hippocampus in diagnosing Alzheimer disease. AJNR Am J Neuroradiol 20(1): 139-44 (1999).
92. Killiany RJ, Gomez-Isla T, Moss M, Kikinis R, Sandor T, Jolesz F, et al. Use of structural magnetic resonance imaging to predict who will get Alzheimer's disease. Ann Neurol 47(4): 430-9 (2000).
93. Supekar K, Menon V, Rubin D, Musen M, Greicius MD. Network analysis of intrinsic functional brain connectivity in Alzheimer's disease. PLoS computational biology 2008; 4(6): e1000100.
94. Wang L, Goldstein FC, Levey AI, Lah JJ, Meltzer CC, Holder CA, et al. White matter hyperintensities and changes in white matter integrity in patients with Alzheimer's disease. Neuroradiology 53(5): 373-81 (2011).
95. Zimny A, Szewczyk P, Trypka E, Wojtynska R, Noga L, Leszek J, et al. Multimodal imaging in diagnosis of Alzheimer's disease and amnestic mild cognitive impairment: value of magnetic resonance spectroscopy, perfusion, and diffusion tensor imaging of the posterior cingulate region. J Alzheimers Dis 27(3): 591-601 (2011).
96. Jacobs HI, Gronenschild EH, Evers EA, Ramakers IH, Hofman PA, Backes WH, et al. Visuospatial processing in early Alzheimer's disease: A multimodal neuroimaging study. Cortex (2012).
97. Cherubini A, Spoletini I, Peran P, Luccichenti G, Di Paola M, Sancesario G, et al. A multimodal MRI investigation of the subventricular zone in mild cognitive impairment and Alzheimer's disease patients. Neurosci lLett 469(2): 214-8 (2010).
98. Cherubini A, Peran P, Spoletini I, Di Paola M, Di Iulio F, Hagberg GE, et al. Combined volumetry and DTI in subcortical structures of mild cognitive impairment and Alzheimer's disease patients. J Alzheimers Dis 19(4): 1273-82 (2010).
99. Fritzsche KH, Stieltjes B, Schlindwein S, van Bruggen T, Essig M, Meinzer HP. Automated MR morphometry to predict Alzheimer's disease in mild cognitive impairment. Int J Comput Assist Radiol Surg 5(6): 623-32 (2010).
100. Westman E, Muehlboeck JS, Simmons A. Combining MRI and CSF measures for classification of Alzheimer's disease and prediction of mild cognitive impairment conversion. Neuroimage 62(1): 229-38 (2012).
101. Nestor SM, Rupsingh R, Borrie M, Smith M, Accomazzi V, Wells JL, et al. Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Brain 131(Pt 9): 2443-54 (2008).
102. van de Pol LA, van der Flier WM, Korf ES, Fox NC, Barkhof F, Scheltens P. Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment. Neurology 69(15): 1491-7 (2007).
103. den Heijer T, Geerlings MI, Hoebeek FE, Hofman A, Koudstaal PJ, Breteler MM. Use of hippocampal and amygdalar volumes on magnetic resonance imaging to predict dementia in cognitively intact elderly people. Arch Gen Psychiatry 63(1): 57-62 (2006).
104. Jack CR, Jr., Shiung MM, Weigand SD, O'Brien PC, Gunter JL, Boeve BF, et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI. Neurology 65(8): 1227-31 (2005).
105. Kantarci K, Petersen RC, Boeve BF, Knopman DS, Weigand SD, O'Brien PC, et al. DWI predicts future progression to Alzheimer disease in amnestic mild cognitive impairment. Neurology 64(5): 902-4 (2005).
106. Thomann PA, Schlafer C, Seidl U, Santos VD, Essig M, Schroder J. The cerebellum in mild cognitive impairment and Alzheimer's disease-a structural MRI study. J Psychiatr Res 42(14): 1198-202 (2008).
107. Braak H, Braak E, Bohl J, Lang W. Alzheimer's disease: amyloid plaques in the cerebellum. J Neurol Sci 93(2-3): 277-87 (1989).
108. Wegiel J, Wisniewski HM, Dziewiatkowski J, Badmajew E, Tarnawski M, Reisberg B, et al. Cerebellar atrophy in Alzheimer's disease-clinicopathological correlations. Brain Res 818(1): 41-50 (1999).
109. Larner AJ. The cerebellum in Alzheimer's disease. Dement Geriatr Cogn Disord 8(4): 203-9 (1997).